FDA Approved: IRBESARTAN — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Irbesartan from Camber Pharmaceuticals, indicating an approved change to the existing ANDA approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Hypertension

Drugs mentioned

• Irbesartan (irbesartan)

Snippet

SUPPL AP for IRBESARTAN (IRBESARTAN)